Health Care Technology Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
Current Valuation | Efficiency | Market Risk | Exp Return | ||||
---|---|---|---|---|---|---|---|
1 | VEEV | Veeva Systems Class | 0.10 | 1.88 | 0.18 | ||
2 | DOCS | Doximity | 0.05 | 5.49 | 0.28 | ||
3 | WAY | Waystar Holding Corp | 0.03 | 2.69 | 0.07 | ||
4 | INSP | Inspire Medical Systems | (0.06) | 3.34 | (0.20) | ||
5 | GDRX | Goodrx Holdings | 0.01 | 2.93 | 0.04 | ||
6 | EVH | Evolent Health | (0.04) | 3.49 | (0.15) | ||
7 | CERT | Certara | (0.02) | 2.91 | (0.06) | ||
8 | TDOC | Teladoc | (0.03) | 4.32 | (0.13) | ||
9 | OMCL | Omnicell | (0.12) | 2.49 | (0.31) | ||
10 | PHR | Phreesia | 0.02 | 3.20 | 0.07 | ||
11 | SDGR | Schrodinger | 0.04 | 4.11 | 0.18 | ||
12 | HSTM | HealthStream | 0.02 | 1.30 | 0.02 | ||
13 | TBRG | TruBridge | 0.24 | 2.69 | 0.64 | ||
14 | ACCD | Accolade | 0.13 | 13.32 | 1.68 | ||
15 | SLP | Simulations Plus | (0.07) | 2.84 | (0.18) | ||
16 | HCAT | Health Catalyst | (0.16) | 3.85 | (0.62) | ||
17 | DH | Definitive Healthcare Corp | (0.06) | 5.90 | (0.34) | ||
18 | OPRX | OPTIMIZERx Corp | 0.13 | 8.29 | 1.08 | ||
19 | ICAD | icad inc | 0.06 | 6.63 | 0.39 | ||
20 | MYND | Myndai, | (0.32) | 4.13 | (1.31) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.